Clinical Trials Directory

Trials / Completed

CompletedNCT06195813

Asparagus Capsule Consumption and Blood Sugar and Lipids and Oxidative Stress

Effects of Asparagus Capsule Consumption on Blood Sugar and Lipids and Oxidative Stress in Overweight and Obese Participants

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Burapha University · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels.

Detailed description

The study design was cross-sectional. Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels. Analysis of covariance was used to analyze parameters between groups and paired t-test was used to analyze parameters intra-group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAsparagus capsuleAsparagus capsule is categorized as dietary supplement.
OTHERPlacebo capsulePlacebo capsule is categorized as other.

Timeline

Start date
2022-12-20
Primary completion
2023-09-14
Completion
2023-09-14
First posted
2024-01-08
Last updated
2024-01-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06195813. Inclusion in this directory is not an endorsement.